Lead-like, drug-like or “Pub-like”: how different are they?

被引:0
|
作者
Tudor I. Oprea
Tharun Kumar Allu
Dan C. Fara
Ramona F. Rad
Lili Ostopovici
Cristian G. Bologa
机构
[1] University of New Mexico School of Medicine,Division of Biocomputing, Department of Biochemistry and Molecular Biology
[2] Sunset Molecular Discovery LLC,undefined
[3] Romanian Academy Institute of Chemistry,undefined
关键词
Chemical probes; Combinatorial chemistry; Computer chemistry; Database filtering; Druglike; Drug research; Hydrogen bonds; Lead discovery; Leadlike; MLSCN; MLSMR; Molecular complexity; Property distribution; Pub-like; PubChem; “Rule of 5” test; WOMBAT;
D O I
暂无
中图分类号
学科分类号
摘要
Academic and industrial research continues to be focused on discovering new classes of compounds based on HTS. Post-HTS analyses need to prioritize compounds that are progressed to chemical probe or lead status. We report trends in probe, lead and drug discovery by examining the following categories of compounds: 385 leads and the 541 drugs that emerged from them; “active” (152) and “inactive” (1488) compounds from the Molecular Libraries Initiative Small Molecule Repository (MLSMR) tested by HTS; “active” (46) and “inactive” (72) compounds from Nature Chemical Biology (NCB) tested by HTS; compounds in the drug development phase (I, II, III and launched), as indexed in MDDR; and medicinal chemistry compounds from WOMBAT, separated into high-activity (5,784 compounds with nanomolar activity or better) and low-activity (30,690 with micromolar activity or less). We examined Molecular weight (MW), molecular complexity, flexibility, the number of hydrogen bond donors and acceptors, LogP—the octanol/water partition coefficient estimated by ClogP and ALOGPS), LogSw (intrinsic water solubility, estimated by ALOGPS) and the number of Rule of five (Ro5) criteria violations. Based on the 50% and 90% distribution moments of the above properties, there were no significant difference between leads of known drugs and “actives” from MLSMR or NCB (chemical probes). “Inactives” from NCB and MLSMR were also found to exhibit similar properties. From these combined sets, we conclude that “Actives” (569 compounds) are less complex, less flexible, and more soluble than drugs (1,651 drugs), and significantly smaller, less complex, less hydrophobic and more soluble than the 5,784 high-activity WOMBAT compounds. These trends indicate that chemical probes are similar to leads with respect to some properties, e.g., complexity, solubility, and hydrophobicity.
引用
收藏
页码:113 / 119
页数:6
相关论文
共 50 条
  • [1] Lead-like, drug-like or "pub-like": How different are they?
    Oprea, Tudor I.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233
  • [2] Lead-like, drug-like or "pub-like": how different are they?
    Oprea, Tudor I.
    Allu, Tharun Kumar
    Fara, Dan C.
    Rad, Ramona F.
    Ostopovici, Lili
    Bologa, Cristian G.
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2007, 21 (1-3) : 113 - 119
  • [3] Visualisation of the chemical space of fragments, lead-like and drug-like molecules in PubChem
    Ruud van Deursen
    Lorenz C. Blum
    Jean-Louis Reymond
    [J]. Journal of Computer-Aided Molecular Design, 2011, 25 : 649 - 662
  • [4] Visualisation of the chemical space of fragments, lead-like and drug-like molecules in PubChem
    van Deursen, Ruud
    Blum, Lorenz C.
    Reymond, Jean-Louis
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2011, 25 (07) : 649 - 662
  • [5] Improving the hit-to-lead process: data-driven assessment of drug-like and lead-like screening hits
    Wunberg, T
    Hendrix, M
    Hillisch, A
    Lobell, M
    Meier, H
    Schmeck, C
    Wild, H
    Hinzen, B
    [J]. DRUG DISCOVERY TODAY, 2006, 11 (3-4) : 175 - 180
  • [6] Lead-like Drugs: A Perspective
    Raymer, Brian
    Bhattacharya, Samit K.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (23) : 10375 - 10384
  • [7] Drug-like index: A new approach to measure drug-like compounds and their diversity
    Xu, J
    Stevenson, J
    [J]. JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2000, 40 (05): : 1177 - 1187
  • [8] Improving the odds in discriminating "Drug-like" from "Non Drug-like" compounds
    Frimurer, TM
    Bywater, R
    Nærum, L
    Lauritsen, LN
    Brunak, S
    [J]. JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2000, 40 (06): : 1315 - 1324
  • [9] Not Drug-like, but Like Drugs: Cnidaria Natural Products
    Laguionie-Marchais, Claire
    Allcock, A. Louise
    Baker, Bill J.
    Conneely, Ellie-Ann
    Dietrick, Sarah G.
    Kearns, Fiona
    McKeever, Kate
    Young, Ryan M.
    Sierra, Connor A.
    Soldatou, Sylvia
    Woodcock, H. Lee
    Johnson, Mark P.
    [J]. MARINE DRUGS, 2022, 20 (01)
  • [10] Endogenous drug-like factors
    Mrozikiewicz, A
    [J]. POLISH JOURNAL OF PHARMACOLOGY, 1998, 50 (06): : 393 - 397